Harvard Bioscience, Inc. (HBIO) vs Veru Inc. (VERU)
A side-by-side comparison of Harvard Bioscience, Inc. and Veru Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HBIO
Harvard Bioscience, Inc.
$8.53HealthcareDelayed quote: Oct 6, 2026, 3:43 PM EDT
VERU
Veru Inc.
$2.49HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
Total return — HBIO vs VERU
growth of $100 · dividends reinvested · last 10yHBIO -67.3% (-10.6%/yr)VERU -78.7% (-14.3%/yr)HBIO compounded faster over this window
HBIO VERU
HBIO vs VERU: by the numbers
- •VERU is the larger company ($40M vs $38M market cap).
- •Both run net losses; VERU's is the smaller (0.00% vs -11.86% net margin).
Metrics side by side
Valuation
| Metric | HBIO | VERU |
|---|---|---|
| P/S ratio | 0.44 | N/A |
| P/B ratio | 5.19 | 1.41 |
| EV / EBITDA | 10.52 | N/A |
Profitability
| Metric | HBIO | VERU |
|---|---|---|
| Gross margin | 58.16% | 0.00% |
| Operating margin | 1.17% | 0.00% |
| Net margin | -11.86% | 0.00% |
| ROE | -140.36% | -47.96% |
| ROIC | 1.99% | -60.64% |
Growth (annualized)
| Metric | HBIO | VERU |
|---|---|---|
| Revenue CAGR (5Y) | -4.62% | N/A |
| Total return CAGR (5Y) | -34.33% | -50.43% |
Frequently asked
- How have HBIO and VERU total returns compared?
- Over the past 10 years, HBIO delivered -11.05% and VERU delivered -14.06% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.